Cargando…
Development of Nanosome-Encapsulated Honokiol for Intravenous Therapy Against Experimental Autoimmune Encephalomyelitis
BACKGROUND: Honokiol has been reported to possess anti-inflammatory and neuroprotective activities. However, the poor aqueous solubility of honokiol limits its clinical application for systemic administration. PURPOSE: This study aims to develop a novel formulation of nanosome-encapsulated honokiol...
Autores principales: | Hsiao, Yai-Ping, Chen, Hui-Ting, Liang, Yu-Chih, Wang, Tse-En, Huang, Kai-Hung, Hsu, Cheng-Chih, Liang, Hong-Jen, Huang, Chung-Hsiung, Jan, Tong-Rong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6954093/ https://www.ncbi.nlm.nih.gov/pubmed/32021162 http://dx.doi.org/10.2147/IJN.S214349 |
Ejemplares similares
-
Systemic exposure to a single dose of ferucarbotran aggravates neuroinflammation in a murine model of experimental autoimmune encephalomyelitis
por: Hsiao, Yai-Ping, et al.
Publicado: (2019) -
Nanoparticulated Honokiol Mitigates Cisplatin-Induced Chronic Kidney Injury by Maintaining Mitochondria Antioxidant Capacity and Reducing Caspase 3-Associated Cellular Apoptosis
por: Liu, Hung-Ting, et al.
Publicado: (2019) -
Pharmacokinetics of Nanosomal Form of Levodopa in Intranasal Administration
por: Nedorubov, Andrey Anatolievich, et al.
Publicado: (2019) -
Counteracting Cisplatin-Induced Testicular Damages by Natural Polyphenol Constituent Honokiol
por: Wang, Tse-En, et al.
Publicado: (2020) -
Intravenous Honokiol in Drug-Resistant Cancer: Two Case Reports
por: Eliaz, Isaac, et al.
Publicado: (2020)